{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:00:54Z","timestamp":1791021654127,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Systemic sclerosis (SSc) is an immune-mediated systemic autoimmune disease with unknown etiology, which has high morbidity and mortality. Current treatments to dispose of this disorder are limited. And there are still no ideal animal models that can fully replicate the four basic pathophysiological features of SSc, including vascular lesions, fibrosis, inflammation, and autoimmunity, let alone animal models specifically designed to study gastrointestinal lesions. It\u2019s essential to seek and establish appropriate animal models to explore the role of gut microbiota in the pathogenesis of SSc. In this study, we found similar gut microbiota aberration in patients of SSc and bleomycin (BLM)-induced mice model through 16S rRNA gene sequencing. In terms of phylum-level differences, the relative abundance of Bacteroidetes was significantly decreased and Firmicutes increased in the SSc patients and the mice. Notably, the genera of Lactobacillus, commonly used as a probiotic additive, was also elevated in SSc patients and BLM mice, which was consistent with a few of studies. Therefore, the model can likely mimic the pathological changes of gut microbiota in patients with SSc, which may offer an important potential platform for the in-depth understanding of gut microbiota aberration in patients with SSc and to devise potential disease-modifying treatments.<\/jats:p>","DOI":"10.3389\/fcimb.2021.647201","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T05:01:07Z","timestamp":1622178067000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Gut Microbiota Aberration in Patients of Systemic Sclerosis and Bleomycin-Induced Mice Model"],"prefix":"10.3389","volume":"11","author":[{"given":"Jungen","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxia","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.2337\/db14-1847","article-title":"Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes","volume":"64","author":"Alkanani","year":"2015","journal-title":"Diabetes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13075-016-1182-z","article-title":"Intestinal Dysbiosis is Common in Systemic Sclerosis and Associated With Gastrointestinal and Extraintestinal Features of Disease","volume":"18","author":"Andr\u00e9asson","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1346-8138.13185","article-title":"Recent Advances in Animal Models of Systemic Sclerosis","volume":"43","author":"Asano","year":"2016","journal-title":"J. Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-4939-0404-4_11","article-title":"Mouse Model of Experimental Dermal Fibrosis: The Bleomycin-Induced Dermal Fibrosis","volume":"1142","author":"Avouac","year":"2014","journal-title":"Methods Mol. Biol. (Clifton N.J.)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/nyas.13736","article-title":"Microbial and Metabolic Multi-Omic Correlations in Systemic Sclerosis Patients","author":"Bellocchi","year":"2018","journal-title":"Ann. New York Acad. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11926-018-0758-9","article-title":"Update on the Gastrointestinal Microbiome in Systemic Sclerosis","volume":"20","author":"Bellocchi","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1002\/art.27647","article-title":"Animal Models of Systemic Sclerosis: Prospects and Limitations","volume":"62","author":"Beyer","year":"2010","journal-title":"Arthritis Rheumatism"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/s0140-6736(17)30933-9","article-title":"Systemic Sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet (London England)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrgastro.2016.99","article-title":"Current Management of the Gastrointestinal Complications of Systemic Sclerosis","volume":"13","author":"Emmanuel","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0232739","DOI":"10.1371\/journal.pone.0232739","article-title":"Fecal Microbiota Transplantation in Systemic Sclerosis: A Double-Blind, Placebo-Controlled Randomized Pilot Trial","volume":"15","author":"Fretheim","year":"2020","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e01548","DOI":"10.1128\/mBio.01548-14","article-title":"Intestinal Dysbiosis Associated With Systemic Lupus Erythematosus","volume":"5","author":"Hevia","year":"2014","journal-title":"mBio"},{"key":"B12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The Microbiota in Adaptive Immune Homeostasis and Disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","article-title":"The Registry of the German Network for Systemic Scleroderma: Frequency of Disease Subsets and Patterns of Organ Involvement","volume":"47","author":"Hunzelmann","year":"2008","journal-title":"Rheumatol. (Oxford England)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and Validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Rheumatism"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial Ecology: Human Gut Microbes Associated With Obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-Omics of the Gut Microbial Ecosystem in Inflammatory Bowel Diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13075-017-1446-2","article-title":"Severe Intestinal Dysbiosis is Prevalent in Primary Sjogren\u2019s Syndrome and Is Associated With Systemic Disease Activity","volume":"19","author":"Mandl","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/rheumatology\/kez160","article-title":"Effect of Probiotics on Gastrointestinal Symptoms and Immune Parameters in Systemic Sclerosis: A Randomized Placebo-Controlled Trial","volume":"58","author":"Marighela","year":"2019","journal-title":"Rheumatol. (Oxford England)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.jid.2017.06.019","article-title":"Early-Life Antibiotic Exposure Causes Intestinal Dysbiosis and Exacerbates Skin and Lung Pathology in Experimental Systemic Sclerosis","volume":"137","author":"Mehta","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"14874","DOI":"10.1038\/s41598-017-14889-6","article-title":"Gut Microbiota Profile in Systemic Sclerosis Patients With and Without Clinical Evidence of Gastrointestinal Involvement","volume":"7","author":"Patrone","year":"2017","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15613","DOI":"10.1038\/s41598-017-15802-x","article-title":"Alteration of the Intestinal Microbiome Characterizes Preclinical Inflammatory Arthritis in Mice and Its Modulation Attenuates Established Arthritis","volume":"7","author":"Rogier","year":"2017","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut Microbiota, Metabolites and Host Immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/1758-2229.12411","article-title":"Mucosa-Attached Bacterial Community in Crohn\u2019s Disease Coheres With the Clinical Disease Activity Index","volume":"8","author":"Sch\u00e4ffler","year":"2016","journal-title":"Environ. Microbiol. Rep."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v8.31119","article-title":"Microbiological and Bioinformatics Analysis of Primary Sjogren\u2019s Syndrome Patients With Normal Salivation","volume":"8","author":"Siddiqui","year":"2016","journal-title":"J. Oral. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature18847","article-title":"The Microbiome and Innate Immunity","volume":"535","author":"Thaiss","year":"2016","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheumatic Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/art.39572","article-title":"Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium","volume":"68","author":"Volkmann","year":"2016","journal-title":"Arthritis Rheumatol. (Hoboken N.J.)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e000134","DOI":"10.1136\/bmjgast-2017-000134","article-title":"Systemic Sclerosis Is Associated With Specific Alterations in Gastrointestinal Microbiota in Two Independent Cohorts","volume":"4","author":"Volkmann","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The Oral and Gut Microbiomes Are Perturbed in Rheumatoid Arthritis and Partly Normalized After Treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.647201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T05:01:08Z","timestamp":1622178068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.647201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":29,"alternative-id":["10.3389\/fcimb.2021.647201"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2021.647201","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"article-number":"647201"}}